Skip to content
Home/Our innovation /Focus areas/Cardiovascular/Cardiovascular disease
Smiling couple hugging in living room

Micro Pancreas

Cardiovascular disease

Share Article
Share to

Micro Pancreas

Cardiovascular diseases are the number one cause of death worldwide, leading to an estimated 31 percent of all deaths. We can help change this course.”

cardio-vascular-disease-photo.jpg

Cardiovascular disease is the number one cause of death worldwide, leading to an estimated 31 percent of all deaths. We can help change this course.

Life-threatening blood clots, if untreated, can lead to deep vein thrombosis (DVT) or pulmonary embolism (PE), conditions which affect nearly 10 million people around the world each year. People who have DVT or PE are at a higher risk of experiencing other major cardiovascular events such as heart attack and stroke.

Although very effective, currently available treatments are often associated with substantive bleeding risks. By expanding our understanding of ways in which patients can benefit from an established oral anticoagulant, while exploring new ways to help patients treat and prevent thrombosis, we are focused on next-generation anticoagulant assets, which are safer and equally effective.